@ARTICLE{
author={Cohen Stanley B,Tuckwell Katie,Kunder Rebecca,Katsumoto Tamiko R,Zhao Rui,Berman Alberto,Damjanov Nemanja S,Fedkov Dmytro,Jeka Slawomir,Genovese Mark C},
year={2019},
title={Efficacy and Safety of Fenebrutinib, a BTK Inhibitor, Compared to Placebo in Rheumatoid Arthritis Patients with Active Disease Despite TNF Inhibitor Treatment: Randomized, Double Blind, Phase 2 Study},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={71},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cohen Stanley B,Tuckwell Katie,Katsumoto Tamiko R,Zhao Rui,Lee Chin,Berman Alberto,Damjanov Nemanja S,Fedkov Dmytro,Jeka Slawomir,Genovese Mark C},
year={2019},
title={Fenebrutinib Compared to Placebo and Adalimumab in Patients with Inadequate Response to Either Methotrexate Therapy Or Prior Tnf Therapy: Phase 2 Study},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={78},
number={},
pages={80-81},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Dawes Peter,Dimic Aleksandar N,Genovese Mark C,van der Heijde Desiree,Jenkins Martin,O'Brien Chris,Oemar Barry,Vencovsky Jiri,Weinblatt Michael},
year={2013},
title={Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.},
journal={ARTHRITIS AND RHEUMATISM},
volume={65},
number={},
pages={S198-S199},
document_type={Meeting Abstract},
}